Catena idebenone regulatory update

Santhera said FDA granted rare pediatric disease designation to idebenone to treat Duchenne muscular

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE